Mark Monane

机构：C2N Diagnostics (United States) · ORCID：0000-0003-1550-4415

发表论文 98 篇 · 总被引 4591 次 · h-index 31

代表论文

• Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care (2024 · JAMA · 被引 392)
• Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease (2024 · Nature Reviews Neurology · 被引 298)
• Plasma phospho-tau217 for Alzheimer’s disease diagnosis in primary and secondary care using a fully automated platform (2025 · Nature Medicine · 被引 181)
• Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid (2024 · Alzheimer s & Dementia · 被引 125)
• Recommendations for clinical implementation of blood‐based biomarkers for Alzheimer's disease (2024 · Alzheimer s & Dementia · 被引 117)
• A polygenic risk score added to a QRISK®2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting (2024 · European Journal of Preventive Cardiology · 被引 49)